Business Standard

Friday, December 27, 2024 | 02:48 PM ISTEN Hindi

Notification Icon
userprofile IconSearch

J&J has applied to South Africa for registering coronavirus vaccine

The US firm's vaccine candidate is one of at least four Covid vaccines being trialled in South Africa, along with candidates being developed by Novavax, AstraZeneca and Pfizer

AstraZeneca wasn't the obvious choice to partner up with Oxford when scientists there started developing a coronavirus shot. Photographer: Mikael Sjoberg/Bloomberg
Premium

South Africa, which officially entered a second wave of infections last week, has more than 860,000 infections and 23,000 deaths, and is the worst-hit country in the continent

Reuters Cape Town
South Africa's pharmaceutical regulator SAHPRA said on Monday it has received its first application to register a Covid-19 vaccine from Johnson & Johnson.

"As of today we have received one application, this was received on Thursday evening from J&J, and we started the review process," said Boitumelo Semete, chief executive of the South African Health Products Regulatory Authority (SAHPRA).
J&J did not immediately respond to an emailed request for comment.
 
The US firm's vaccine candidate is one of at least four Covid vaccines being trialled in South Africa, along with candidates being developed by Novavax, AstraZeneca and Pfizer.
 
Semete told a news

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in